Glycine

Glycine is the smallest of the amino acids, non-essential amino acid occuring as a constituents of many proteins. Chemically itaminoacetic acid. It is a glycogenic and participates in variety of synthetic reactions. Glycine is used with antacid in stomach hyperacidity, also with aspirin to reduce its stomach irritation.

Brands
CICATRIN CICATRIN PURISOL N.S PURISOL GLYCINE AMINOPLASMAL-L10 AMINOPLASMAL® HEPA NUTRIFLLEX SPECIAL NUTRIFLLEX SPECIAL NUTRIFLLEX SPECIAL NUTRIFLEX PLUS NUTRIFLEX PLUS PROMOD LIPOSYN II 20% AMISOL
Adult Dose
Dose: 40 to 90 g
Single Dose: 65 (65)
Frequency: 24 hourly
Route: PO
Instructions: For management of schizophrenia
Neonatal
Paedriatic
Characteristics
Glycine also known as Aminoethonoic Acid, Aminoethonoic Acid. . It is of Synthetic origin and belongs to Aminoacid. . The Molecular Weight of Glycine is 75.05.
Contraindications
Glycine is contraindicated in conditions like Anuria.
Effects
The severe or irreversible adverse effects of Glycine, which give rise to further complications include Pulmonary toxicity, Cardiovascular toxicity, Hyperammonemia.The symptomatic adverse reactions produced by Glycine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Electrolyte imbalance.
Indications
Glycine is primarily indicated in conditions like Bladder irrigation, Urogenital tract inflammation, and can also be given in adjunctive therapy as an alternative drug of choice in Hyperacidity.
Interactions
No data regarding the interactions of Glycine was found.
Interfrence
Risks
If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Irrigation soln
Warnings
Glycine should be used with caution in patients with liver impairment. Avoid use in patients with anuria.Hepatic impairment as any absorption and consequent metabolism may cause hyperammonaemia. Cardiopulmonary dysfuntion . CV status before and during treatment in pateints with cardiac disease.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.